Harrington Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.78M Sell
25,819
-135
-0.5% -$9.32K 0.94% 38
2025
Q1
$1.8M Sell
25,954
-221
-0.8% -$15.3K 1.02% 36
2024
Q4
$2.25M Buy
26,175
+80
+0.3% +$6.88K 1.24% 29
2024
Q3
$3.11M Sell
26,095
-1,095
-4% -$130K 1.7% 20
2024
Q2
$3.88M Sell
27,190
-3,428
-11% -$489K 2.2% 14
2024
Q1
$3.93M Sell
30,618
-1,296
-4% -$166K 2.25% 13
2023
Q4
$3.3M Sell
31,914
-2,660
-8% -$275K 2.05% 15
2023
Q3
$3.14M Sell
34,574
-572
-2% -$52K 2.16% 13
2023
Q2
$2.84M Sell
35,146
-110
-0.3% -$8.9K 1.87% 20
2023
Q1
$2.81M Sell
35,256
-220
-0.6% -$17.5K 1.94% 18
2022
Q4
$2.4M Sell
35,476
-254
-0.7% -$17.2K 1.74% 24
2022
Q3
$1.78M Hold
35,730
1.38% 28
2022
Q2
$1.99M Buy
35,730
+40
+0.1% +$2.23K 1.48% 22
2022
Q1
$1.98M Sell
35,690
-76
-0.2% -$4.22K 1.19% 29
2021
Q4
$2M Sell
35,766
-570
-2% -$31.9K 1.08% 31
2021
Q3
$1.74M Sell
36,336
-200
-0.5% -$9.6K 1.01% 33
2021
Q2
$1.53M Sell
36,536
-300
-0.8% -$12.6K 0.91% 35
2021
Q1
$1.24M Sell
36,836
-74
-0.2% -$2.5K 0.78% 42
2020
Q4
$1.29M Sell
36,910
-2,174
-6% -$75.9K 0.86% 39
2020
Q3
$1.36M Sell
39,084
-2,800
-7% -$97.2K 0.96% 37
2020
Q2
$1.37M Buy
41,884
+50
+0.1% +$1.64K 1.07% 36
2020
Q1
$1.26M Sell
41,834
-350
-0.8% -$10.5K 1.18% 34
2019
Q4
$1.22M Sell
42,184
-1,996
-5% -$57.8K 0.95% 40
2019
Q3
$1.14M Sell
44,180
-250
-0.6% -$6.46K 0.94% 39
2019
Q2
$1.13M Sell
44,430
-40
-0.1% -$1.02K 0.93% 39
2019
Q1
$1.16M Sell
44,470
-3,130
-7% -$81.9K 1% 40
2018
Q4
$1.1M Sell
47,600
-700
-1% -$16.1K 1.05% 41
2018
Q3
$1.14M Sell
48,300
-1,300
-3% -$30.6K 0.9% 41
2018
Q2
$1.14M Sell
49,600
-4,700
-9% -$108K 0.97% 40
2018
Q1
$1.34M Buy
54,300
+580
+1% +$14.3K 1.1% 40
2017
Q4
$1.44M Sell
53,720
-470
-0.9% -$12.6K 1.2% 35
2017
Q3
$1.31M Buy
+54,190
New +$1.31M 1.25% 34